Stockreport

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF ENHERTU® late-breaking data from DESTINY-Breast06 continues to redefine the classification and treatment of metastatic breast cancer with new data in patients with HER2 [Read more]